๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Considerations in the Development of Drugs to Treat Sarcopenia

โœ Scribed by Eric P. Brass; Kathy E. Sietsema

Book ID
109132559
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
73 KB
Volume
59
Category
Article
ISSN
0002-8614

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Statistical Considerations in the Intent
Statistical Considerations in the Intent-to-Treat Principle
โœ John M. Lachin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 249 KB

This paper describes some of the statistical considerations in the intent-to-treat design and analysis of clinical trials. The pivotal property of a clinical trial is the assignment of treatments to patients at random. Randomization alone, however, is not sufficient to provide an unbiased comparison

Role of drug metabolism in drug research
Role of drug metabolism in drug research and development: Basic considerations
โœ John E. Baer ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 445 KB ๐Ÿ‘ 1 views

Data from the rapid systematic study of the fate of a new drug in rats and dogs can aid the design of pharmacological and safety tests and can provide a basis for biopharmaceutic and Phase I clinical trials. Keyphrases Drug metabolism-role in drug research and development, symposium Biopharmaceutics